Dr. Alex Marson, a medical doctor and scientist, joins Andrew Huberman to discuss the workings of the immune system, cancer treatments, and gene editing technologies. The conversation highlights the convergence of biology, DNA sequencing, and molecular biology, enabling interventions at the root causes of diseases. Marson details the roles of innate and adaptive immune systems, T-cells, and B-cells in protecting against infections and maintaining balance within the body. The discussion covers cancer's genetic basis, mutations, and the potential of immunotherapy, including CAR T-cells, to target cancer cells. Marson shares the success story of Emily Whitehead, the first pediatric patient cured with CAR T-cells, and explores the transformative CRISPR technology for rewriting DNA sequences and programming cell behavior.
Sign in to continue reading, translating and more.
Continue
